Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Metabiologics Inc
Profile last edited on: 4/11/2016      CAGE: 1ME68      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1999
First Award
1999
Latest Award
2002
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

505 South Rosa Road
Madison, WI 53719
   (608) 441-2730
   info@metabiologics.com
   www.metabiologics.com
Location: Single
Congr. District: 02
County: Dane

Public Profile

Metabiologics Inc. is currently manufacturing and selling all seven serotypes of botulinum toxin for use by accredited researchers on a worldwide basis. Metabiologics manufactures toxin products to the highest industry standard for purity and specific activity. Customized product specifications and order quantities are available upon request. Antibodies to botulinum toxins and related assays are available.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
1
Conversion Rate
33.33%
Phase I Dollars
$290,374
Phase II Dollars
$458,172
Total Awarded
$748,546

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2002 1 NIH $98,619
Project Title: Pharmaceutical delivery platform targeting motor neurons
1999 1 NIH $92,185
Project Title: Targeting Pharmaceuticals To Motor Neurons
1999 2 Army $557,742
Project Title: Development of Delivery Vehicle Targeting Cholinergic

Key People / Management

  Eric Johnson -- President

  Michael C Goodnough

Company News

There are no news available.